Minerva Neurosciences NERV
NASDAQ NERV
$2.46 -0.17 (-6.27%)
As of: Nov 10, 2026 · 2:31 PM EST

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014)

Updated

Minerva Neurosciences' Interest Coverage Ratio came in at -10.22 for Q2 2014.

Analysis

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 28.50
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 10.28
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 7.27
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 5.68
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 12.87
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Minerva Neurosciences 121.62 Mn -126.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22
API Access

Minerva Neurosciences Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=NERV&period=max&api_key=YOUR_API_KEY